HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liver Abscess

Solitary or multiple collections of PUS within the liver as a result of infection by bacteria, protozoa, or other agents.
Also Known As:
Abscess, Liver; Abscesses, Hepatic; Abscesses, Liver; Hepatic Abscess; Hepatic Abscesses; Liver Abscesses; Abscess, Hepatic
Networked: 1586 relevant articles (93 outcomes, 80 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Abscess
2. Infections
3. Liver Abscess
4. Peritonitis
5. Endocarditis

Experts

1. Fung, Chang-Phone: 11 articles (01/2017 - 04/2004)
2. Petri, William A: 9 articles (01/2022 - 10/2002)
3. Wang, Jin-Town: 8 articles (12/2020 - 07/2004)
4. Nagaraja, T G: 7 articles (06/2021 - 07/2007)
5. Chang, Feng-Yee: 7 articles (01/2016 - 07/2003)
6. Lin, Yi-Tsung: 6 articles (10/2020 - 01/2013)
7. Archuleta, Sophia: 6 articles (01/2020 - 07/2011)
8. Lin, Jung-Chung: 6 articles (01/2016 - 11/2004)
9. Lin, Tzu-Lung: 5 articles (12/2020 - 01/2008)
10. Heller, Theo: 5 articles (01/2018 - 08/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Liver Abscess:
1. Anti-Bacterial Agents (Antibiotics)IBA
2. TylosinIBA
3. 4-phenyl-1,2,4-triazoline-3,5-dioneIBA
4. VaccinesIBA
5. Ciprofloxacin (Cipro)FDA LinkGeneric
12/01/2017 - "Ciprofloxacin treatment for cryptogenic Klebsiella pneumoniae liver abscesses."
12/01/1990 - "There are limited data concerning its use in the treatment of shigella dysentery but, in appropriate situations, ciprofloxacin is effective treatment for salmonella enteritis and is also effective in infections complicated by septicaemia and bone and liver abscesses. "
05/01/1994 - "A clinically favorable response was achieved using i.v. ciprofloxacin in 48 (75%) of 64 patients with pneumonia; 4 (80%) of 5 patients with other lower respiratory tract infection (LRTI); 21 (88%) of 24 patients with pyelonephritis; all 7 (100%) patients with complicated cystitis; 16 (94%) of 17 patients with other complicated urinary tract infection (UTI); all 8 (100%) patients with cellulitis; both (100%) patients with infected ulcer; 4 (80%) of 5 patients with other skin or skin structure infection; 5 (83%) of 6 patients with bone infections; all 8 (100%) patients with septicemia; the 1 (100%) patient with acute cholecystitis; and the 1 (100%) patient with liver abscess. "
01/01/2023 - "A cost-minimization analysis was conducted for Klebsiella pneumoniae liver abscess (KLA) patients enrolled in a randomized controlled trial which found oral ciprofloxacin to be non-inferior to intravenous (IV) ceftriaxone in terms of clinical outcomes. "
01/01/2023 - "Oral ciprofloxacin is less costly than IV ceftriaxone in the treatment of Klebsiella liver abscess, largely driven by reduced outpatient service costs.Trial"
6. Metronidazole (Metric)FDA LinkGeneric
7. Proteins (Proteins, Gene)FDA Link
8. Amphotericin B (Amphotericin)FDA LinkGeneric
9. Meropenem (Merrem)FDA LinkGeneric
10. leukotoxinIBA

Therapies and Procedures

1. Therapeutics
2. Catheters
3. Endoscopic Sphincterotomy
4. Length of Stay
5. Drug Therapy (Chemotherapy)